Three months of yoga before surgery revealed a surprising difference in stress hormones
As patients prepared for bariatric surgery, researchers examined whether three months of yoga could influence stress hormones, inflammation,…
New iron deficiency guidelines raise key blood test cutoffs
Could current blood test cutoffs be missing iron deficiency? New guidelines recommend higher ferritin thresholds for key patient…
Weight-loss drug use surges as lawsuits and side-effect concerns grow
LAS VEGAS (FOX5) — New Gallup data shows 11% of U.S. adults are taking weight loss drugs such…
Ozempic’s impact on obesity care: Robotic surgeon explains why bariatric surgery remains essential even with weight loss medicines
Ozempic and other weight loss medicines’ popularity has changed conversations around obesity. Yet, according to Dr Ashish Gautam,…
Bariatric surgery restores menstrual cycles and reduces polycystic ovaries in obese women
Metabolic bariatric surgery improves menstrual cycle frequency and symptoms of polycystic ovaries in women living with obesity, a…
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Tennis legend Serena Williams is speaking openly about her decision to use a GLP-1 weight-loss medication, adding her…
Diet helps people lose weight regardless of genetic obesity risk
A six-month clinical trial found that people with a high genetic risk for obesity benefited just as much…
Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care
Real-world data suggest newer obesity drugs may carry different mental health profiles, with lower rates of several recorded…
Experts reframe steatotic liver disease as a dynamic continuum
The classification of steatotic liver disease (SLD) is undergoing a major conceptual transformation. In a recent article published…
Lost weight is less likely to return when exercise follows obesity treatment
Exercise may offer a modest but measurable defense against weight regain after dieting or bariatric surgery, but the…
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity…
GLP-1 drugs combined with surgery yield superior weight loss results
People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery…